These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 22821065)
21. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease. Verma R; Nehru B Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462 [TBL] [Abstract][Full Text] [Related]
22. Effect of Flavonoids against Parkinson's Disease. Varshney H; Siddique YH Cent Nerv Syst Agents Med Chem; 2024; 24(2):145-165. PubMed ID: 38305395 [TBL] [Abstract][Full Text] [Related]
23. Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease. Zhang Z; Li G; Szeto SSW; Chong CM; Quan Q; Huang C; Cui W; Guo B; Wang Y; Han Y; Michael Siu KW; Yuen Lee SM; Chu IK Free Radic Biol Med; 2015 Jul; 84():331-343. PubMed ID: 25769424 [TBL] [Abstract][Full Text] [Related]
24. Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson's Disease. Das NR; Sharma SS CNS Neurol Disord Drug Targets; 2015; 14(8):1024-30. PubMed ID: 25808897 [TBL] [Abstract][Full Text] [Related]
25. Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease. Liu F; Nguyen JL; Hulleman JD; Li L; Rochet JC J Neurochem; 2008 Jun; 105(6):2435-53. PubMed ID: 18331584 [TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effect of modified Chungsimyeolda-tang, a traditional Korean herbal formula, via autophagy induction in models of Parkinson's disease. Bae N; Chung S; Kim HJ; Cha JW; Oh H; Gu MY; Oh MS; Yang HO J Ethnopharmacol; 2015 Jan; 159():93-101. PubMed ID: 25449460 [TBL] [Abstract][Full Text] [Related]
27. Modulation of endoplasmic reticulum stress in Parkinson's disease. Tsujii S; Ishisaka M; Hara H Eur J Pharmacol; 2015 Oct; 765():154-6. PubMed ID: 26297973 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotective and neurotoxic roles of levodopa (L-DOPA) in neurodegenerative disorders relating to Parkinson's disease. Kostrzewa RM; Kostrzewa JP; Brus R Amino Acids; 2002; 23(1-3):57-63. PubMed ID: 12373519 [TBL] [Abstract][Full Text] [Related]
29. Possible neuroprotective therapy for Parkinson's disease. Ogawa N Acta Med Okayama; 1995 Aug; 49(4):179-85. PubMed ID: 7502677 [TBL] [Abstract][Full Text] [Related]
30. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease. Rekha KR; Inmozhi Sivakamasundari R Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137 [TBL] [Abstract][Full Text] [Related]
31. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity. Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839 [TBL] [Abstract][Full Text] [Related]
32. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress. Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317 [TBL] [Abstract][Full Text] [Related]
33. Propensity of Selaginella delicatula aqueous extract to offset rotenone-induced oxidative dysfunctions and neurotoxicity in Drosophila melanogaster: Implications for Parkinson's disease. Girish C; Muralidhara Neurotoxicology; 2012 Jun; 33(3):444-56. PubMed ID: 22521218 [TBL] [Abstract][Full Text] [Related]
34. Paeonolum protects against MPP(+)-induced neurotoxicity in zebrafish and PC12 cells. Lu XL; Lin YH; Wu Q; Su FJ; Ye CH; Shi L; He BX; Huang FW; Pei Z; Yao XL BMC Complement Altern Med; 2015 Apr; 15():137. PubMed ID: 25925762 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of endoplasmic reticulum stress-activated IRE1α-TRAF2-caspase-12 apoptotic pathway is involved in the neuroprotective effects of telmisartan in the rotenone rat model of Parkinson's disease. Tong Q; Wu L; Jiang T; Ou Z; Zhang Y; Zhu D Eur J Pharmacol; 2016 Apr; 776():106-15. PubMed ID: 26879867 [TBL] [Abstract][Full Text] [Related]
36. New hope for mechanism-based treatment of Parkinson's disease. Bradbury J Drug Discov Today; 2005 Jan; 10(2):80-1. PubMed ID: 15718152 [TBL] [Abstract][Full Text] [Related]
37. Intervention of mitochondrial dysfunction-oxidative stress-dependent apoptosis as a possible neuroprotective mechanism of α-lipoic acid against rotenone-induced parkinsonism and L-dopa toxicity. Abdin AA; Sarhan NI Neurosci Res; 2011 Dec; 71(4):387-95. PubMed ID: 21889550 [TBL] [Abstract][Full Text] [Related]
38. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Lim JH; Kim KM; Kim SW; Hwang O; Choi HJ Pharmacol Res; 2008 May; 57(5):325-31. PubMed ID: 18455424 [TBL] [Abstract][Full Text] [Related]
39. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691 [TBL] [Abstract][Full Text] [Related]
40. Isolongifolene mitigates rotenone-induced dopamine depletion and motor deficits through anti-oxidative and anti-apoptotic effects in a rat model of Parkinson's disease. Balakrishnan R; Vijayraja D; Mohankumar T; Manimaran D; Ganesan P; Choi DK; Elangovan N J Chem Neuroanat; 2021 Mar; 112():101890. PubMed ID: 33220427 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]